Moderna: We Can Change Vaccine 'Code' To Fight New Variants

Dr. Noubar Afeyan, Chairman and co-Founder of Moderna and Founder & CEO of Flagship Pioneering, on their next generation covid-19 vaccine and distribution outlook. Ed Al-Hussainy, Senior Interest Rates and Currencies Analyst for Columbia Threadneedle Investments, on the Fed, the dollar, and currencies. Max Abelson, Bloomberg finance reporter, on Trump’s ailing empire. Chris Bryant, Bloomberg Opinion industrials columnist, on his column: “Elon Musk Has a Serious Rival - the TechnoKaiser.” Hosted by Paul Sweeney and Matt Miller. Hosted by Paul Sweeney and Matt Miller. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com